Celyad Oncology SA (CELYAD ONCOLOGY) aksje
CYAD.BR
€0.2840-0.0060 (-2.07%)
Laster graf...
CELYAD ONCOLOGY
Market Cap
$12,712,381
Åpning0.2800
Høy0.2890
Lav0.2720
Volum18.19k
P/E14.20
Markedsverdi12.71M
52-ukers høy0.6500
52-ukers lav0.1600
Gj.sn. volum16.18k
UtbytteN/A
Beta1.19
EPS0.0200
Om Celyad Oncology SA (CELYAD ONCOLOGY) aksje
Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
Selskapsinformasjon
Børs: Brussels (BRU)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Axis Business Park
1435 Mont-Saint-Guibert, Belgium
1435 Mont-Saint-Guibert, Belgium
Telefon: + 32 1 039 41 00
Nettside: https://celyad.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål